AZN vs IOVA · P/E 28, $288.38B cap vs rev $170.7M
AstraZeneca PLC (AZN) versus Iovance Biotherapeutics Inc (IOVA) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Iovance Biotherapeutics Inc (IOVA) is a biotechnology company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported IOVA revenue for 2026-06-30 was $170.7M. Net income was -$126.4M. IOVA currently screens at market cap $1.89B.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. IOVA currently screens at market cap $1.89B.
Not investment advice. Open the AZN and IOVA stock pages for the full models.
Not investment advice.